MPM ASSET MANAGEMENT INVESTORS BV2018 LLC — SEC insider filings

SEC reporting owner CIK 1734817. 27 insider filings on record with FilingPulse; latest filed 2026-09-09.

Transaction summary — filings shown

Covers all 27 filings on record, filed 2020-09-23 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
iTeos Therapeutics, Inc. (ITOS)—19—73 legs · 1,535,388 sh · $34,207,3773
Aktis Oncology, Inc. (AKTS)10% owner11 leg · 1,112,777 sh · $20,029,986—6
Entrada Therapeutics, Inc. (TRDA)10% owner61 leg · 100,000 sh · $2,000,00014 legs · 540,669 sh · $4,517,5814
Dyne Therapeutics, Inc. (DYN)10% owner1——9

Insider filings — MPM ASSET MANAGEMENT INVESTORS BV2018 LLC

FiledFormIssuerReported transactionsSource
2026-09-094Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 38,500 @ $7.11 · Sale (S): 192,500 @ $7.41 · Sale (S): 28,837 @ $7.13EDGAR
2026-09-034Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 29,088 @ $7.06 · Sale (S): 25,131 @ $7.19 · Sale (S): 32,263 @ $7.17EDGAR
2026-08-314Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 38,922 @ $7.20 · Sale (S): 3,733 @ $7.01 · Sale (S): 44,259 @ $6.99EDGAR
2026-08-264Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 21,623 @ $7.34 · Sale (S): 26,522 @ $7.54 · Sale (S): 14,569 @ $7.06EDGAR
2026-01-144Aktis Oncology, Inc. (AKTS)
jointly with MPM BIOVENTURES 2018, L.P., EVNIN LUKE, MPM BIOVENTURES 2018 (B), L.P., MPM BioVentures 2018 LLC, MPM BioVentures 2018 GP LLC, MPM ONCOLOGY INNOVATIONS FUND LP, MPM Oncology Innovations Fund GP LLC
Conversion (C): 1,314,262 · Conversion (C): 5,914,197 · Conversion (C): 1,577,119 · Purchase (P): 1,112,777 @ $18 · Conversion (C): 5,000,000 (derivative) @ $0 · Conversion (C): 22,500,000 (derivative) @ $0 · +1 moreEDGAR
2025-05-154iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BIOVENTURES 2018 (B), L.P., EVNIN LUKE, Foley Todd
Sale (S): 630,191 @ $8.06EDGAR
2024-12-124Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 22,935 @ $20.77 · Sale (S): 21,787 @ $20.23EDGAR
2022-01-064iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 94,745 @ $42.05 · Sale (S): 19,366 @ $43.20 · Sale (S): 6,768 @ $45.32 · Sale (S): 7,671 @ $46.47 · Sale (S): 18,135 @ $42.03EDGAR
2021-12-074iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 17,569 @ $34.68 · Sale (S): 2,419 @ $35.44 · Sale (S): 179 @ $36.26 · Sale (S): 8,469 @ $32.35 · Sale (S): 1,171 @ $33.57 · Sale (S): 508 @ $34.08 · +3 moreEDGAR
2021-12-024iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 5,861 @ $34.62 · Sale (S): 28,076 @ $35.19 · Sale (S): 6,042 @ $33.82 · Sale (S): 5,457 @ $34.61 · Sale (S): 896 @ $35.34 · Sale (S): 29,757 @ $33.74 · +1 moreEDGAR
2021-11-304iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 6,545 @ $35.49 · Sale (S): 6,129 @ $36.03 · Sale (S): 10,073 @ $34.46 · Sale (S): 298 @ $35.37EDGAR
2021-11-244iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Other (J): 15,671 @ $0 · Sale (S): 9,307 @ $37.16 · Sale (S): 11,807 @ $37.81 · Sale (S): 19,645 @ $36.21 · Sale (S): 359 @ $36.50 · Sale (S): 4,868 @ $35.20 · +2 moreEDGAR
2021-11-044Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Conversion (C): 3,816,760 · Conversion (C): 509,024 · Purchase (P): 100,000 @ $20 · Conversion (C): 27,617,675 (derivative) @ $0 · Conversion (C): 3,683,241 (derivative) @ $0EDGAR
2021-10-184iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 8,893 @ $27.53 · Sale (S): 2,039 @ $28.01 · Sale (S): 6,167 @ $27.14EDGAR
2021-10-144iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 8,521 @ $27.09 · Sale (S): 20,929 @ $27.13 · Sale (S): 27,320 @ $27.30EDGAR
2021-10-124iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 1,149 @ $27 · Sale (S): 2,032 @ $27.01 · Sale (S): 48,812 @ $27.24EDGAR
2021-10-054iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 6,855 @ $27 · Sale (S): 20,711 @ $27.06EDGAR
2021-09-304iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 19,214 @ $27 · Sale (S): 2,292 @ $27EDGAR
2021-09-274iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 36,213 @ $27.96 · Sale (S): 717 @ $28.38 · Sale (S): 4,913 @ $27.81 · Sale (S): 11,625 @ $27.09EDGAR
2021-09-234iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 19,635 @ $27.47 · Sale (S): 14,294 @ $27.54EDGAR
2021-09-204iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 21,253 @ $28.47 · Sale (S): 45,698 @ $28.82 · Sale (S): 10,602 @ $27.03 · Sale (S): 13,701 @ $27.84EDGAR
2021-09-164iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 17,938 @ $27.50 · Sale (S): 3,623 @ $27.99 · Sale (S): 23,113 @ $27.79 · Sale (S): 991 @ $28.15EDGAR
2021-09-134iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 22,725 @ $28.97 · Sale (S): 6,760 @ $27.86 · Sale (S): 6,771 @ $28.73 · Sale (S): 21,384 @ $27.64EDGAR
2021-09-084iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 30,474 @ $29.18 · Other (J): 31,340 @ $0 · Sale (S): 11,152 @ $28.61 · Sale (S): 940 @ $29.10EDGAR
2021-04-134iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 119 @ $29.99EDGAR
2021-04-094iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P.
Sale (S): 3,164 @ $32.07 · Sale (S): 1,842 @ $32.84 · Sale (S): 777 @ $33.84 · Other (J): 15,670 @ $0 · Sale (S): 19,057 @ $30.51 · Sale (S): 247 @ $31.01EDGAR
2020-09-234Dyne Therapeutics, Inc. (DYN)
jointly with MPM BIOVENTURES 2018, L.P., MPM BIOVENTURES 2018 (B), L.P., MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC, EVNIN LUKE, Foley Todd, GADICKE ANSBERT
Conversion (C): 4,614,943 · Conversion (C): 245,279 · Conversion (C): 91,081 · Conversion (C): 13,980,992 (derivative) @ $0 · Conversion (C): 743,076 (derivative) @ $0 · Conversion (C): 275,932 (derivative) @ $0 · +3 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1734817 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs